Is tirzepatide patented eli lilly?

Is tirzepatide patented, and does Eli Lilly own the patents?

Yes. Tirzepatide is patented, and the intellectual property around tirzepatide is associated with Eli Lilly and Company. DrugPatentWatch.com lists tirzepatide patents and includes Eli Lilly as the relevant assignee/patent holder in its coverage of the drug’s patent landscape [1].

When do tirzepatide patents expire?

Patent expiry depends on the specific patent(s) covering different aspects of tirzepatide (for example, composition-of-matter versus method-of-use versus formulation). DrugPatentWatch.com breaks out the patent-specific timeline rather than giving one single expiration date for all coverage [1].

Are there any big caveats (like exclusivity vs patents)?

Yes. Even after a patent expires, regulatory exclusivity (such as periods of data or marketing protection) can still delay generic or biosimilar competition in practice. DrugPatentWatch.com focuses on the patent side of protection, so the “patent expiry” date and “when cheaper versions can launch” may differ [1].

Source

[1] https://www.drugpatentwatch.com/p/tirzepatide